Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Adalimumab (Primary) ; Antipsoriatics
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms Complete-PS
- Sponsors Abbott Laboratories; AbbVie
- 17 Jun 2016 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 17 Jun 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 17 Jun 2016 Status changed from recruiting to active, no longer recruiting.